| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,081 |
30,657 |
$6.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
25,725 |
24,089 |
$6.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,696 |
26,163 |
$4.19M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,735 |
6,474 |
$2.16M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
23,278 |
22,064 |
$1.92M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,711 |
5,595 |
$1.74M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
36,487 |
31,077 |
$1.57M |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,456 |
6,179 |
$1.07M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,021 |
1,938 |
$993K |
| 80053 |
Comprehensive metabolic panel |
45,461 |
38,369 |
$974K |
| G0378 |
Hospital observation service, per hour |
2,646 |
2,421 |
$969K |
| 93458 |
|
490 |
483 |
$840K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,821 |
5,498 |
$597K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,756 |
16,995 |
$597K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
52,313 |
43,041 |
$561K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,342 |
2,250 |
$552K |
| 93017 |
|
3,163 |
3,064 |
$496K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,746 |
10,265 |
$493K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
6,900 |
6,261 |
$484K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,811 |
7,434 |
$475K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,462 |
5,637 |
$471K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,695 |
1,638 |
$427K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
926 |
894 |
$405K |
| 49083 |
|
1,126 |
531 |
$361K |
| 71045 |
Radiologic examination, chest; single view |
11,058 |
10,075 |
$356K |
| 71046 |
Radiologic examination, chest; 2 views |
7,707 |
7,439 |
$344K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,120 |
1,065 |
$333K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,119 |
2,669 |
$295K |
| C1776 |
Joint device (implantable) |
195 |
195 |
$289K |
| 84484 |
|
17,722 |
13,196 |
$260K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,340 |
1,312 |
$247K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
834 |
821 |
$224K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,355 |
6,398 |
$221K |
| 36415 |
Collection of venous blood by venipuncture |
56,629 |
45,176 |
$217K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,408 |
1,941 |
$208K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,212 |
2,141 |
$193K |
| 83690 |
|
12,688 |
11,730 |
$183K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,990 |
1,922 |
$172K |
| 84703 |
|
10,116 |
9,576 |
$167K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14,098 |
13,106 |
$164K |
| 99152 |
|
3,027 |
2,896 |
$161K |
| 93976 |
|
1,343 |
1,321 |
$149K |
| 87040 |
|
5,464 |
3,036 |
$149K |
| 71250 |
|
1,050 |
1,025 |
$146K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,078 |
8,546 |
$135K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,812 |
1,755 |
$133K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,400 |
2,288 |
$125K |
| 82962 |
|
16,570 |
7,528 |
$124K |
| 70486 |
|
651 |
638 |
$123K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,984 |
6,425 |
$120K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
635 |
620 |
$120K |
| 81001 |
|
18,083 |
16,911 |
$117K |
| 99153 |
Mod sedat endo service >5yrs |
1,954 |
1,862 |
$114K |
| C1769 |
Guide wire |
3,766 |
3,543 |
$114K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
872 |
612 |
$105K |
| 73562 |
|
1,575 |
1,468 |
$105K |
| 83605 |
|
5,191 |
3,913 |
$105K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,595 |
1,526 |
$104K |
| 93970 |
|
905 |
873 |
$104K |
| 93971 |
|
1,339 |
1,300 |
$103K |
| 73030 |
|
1,518 |
1,413 |
$101K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
279 |
269 |
$101K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,006 |
955 |
$97K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
341 |
339 |
$94K |
| 83735 |
|
9,948 |
7,523 |
$90K |
| 83880 |
|
3,719 |
3,349 |
$87K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
331 |
325 |
$87K |
| 96376 |
|
3,296 |
2,496 |
$86K |
| 87631 |
|
1,048 |
1,022 |
$85K |
| 93296 |
|
4,024 |
3,886 |
$81K |
| 93350 |
|
224 |
224 |
$76K |
| 85610 |
|
11,953 |
9,848 |
$74K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,959 |
1,868 |
$73K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
658 |
647 |
$65K |
| 73610 |
|
916 |
884 |
$65K |
| 73130 |
|
1,195 |
1,142 |
$64K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
209 |
205 |
$61K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,947 |
2,766 |
$54K |
| 73630 |
|
952 |
917 |
$54K |
| 97163 |
|
1,104 |
1,055 |
$53K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,265 |
1,199 |
$51K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,578 |
8,342 |
$49K |
| 97167 |
|
911 |
884 |
$47K |
| 93925 |
|
558 |
542 |
$47K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,953 |
2,804 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,944 |
1,911 |
$45K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
2,006 |
1,953 |
$43K |
| 93246 |
|
814 |
797 |
$40K |
| 94761 |
|
3,197 |
1,415 |
$39K |
| 86850 |
|
3,852 |
3,677 |
$39K |
| 72131 |
|
231 |
226 |
$39K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
637 |
613 |
$37K |
| 85379 |
|
2,410 |
2,283 |
$35K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,282 |
5,407 |
$35K |
| 76536 |
|
353 |
347 |
$34K |
| 99490 |
Ccm add 20min |
1,036 |
1,035 |
$34K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
286 |
281 |
$33K |
| 72100 |
|
429 |
420 |
$32K |
| 87186 |
|
2,091 |
1,911 |
$31K |
| 87077 |
|
2,885 |
2,622 |
$31K |
| 93880 |
|
293 |
287 |
$31K |
| 76830 |
Ultrasound, transvaginal |
323 |
319 |
$30K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
660 |
646 |
$30K |
| 93922 |
|
444 |
432 |
$29K |
| 73502 |
|
662 |
637 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,417 |
1,385 |
$28K |
| 67113 |
|
12 |
12 |
$28K |
| 85730 |
|
3,655 |
3,393 |
$28K |
| J2704 |
Injection, propofol, 10 mg |
4,362 |
4,012 |
$26K |
| 64635 |
|
57 |
54 |
$26K |
| 93325 |
|
423 |
409 |
$25K |
| 86900 |
|
4,038 |
3,841 |
$25K |
| 81003 |
|
6,742 |
6,438 |
$24K |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
53 |
52 |
$23K |
| 87081 |
|
1,651 |
1,619 |
$23K |
| 84702 |
|
946 |
913 |
$22K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
232 |
230 |
$22K |
| 73110 |
|
404 |
389 |
$21K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
287 |
274 |
$20K |
| 93320 |
|
285 |
280 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
515 |
503 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
517 |
505 |
$18K |
| 82803 |
|
947 |
749 |
$18K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,475 |
1,441 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,125 |
1,996 |
$17K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,974 |
1,873 |
$16K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
12 |
12 |
$16K |
| 86901 |
|
4,039 |
3,841 |
$16K |
| 75625 |
|
13 |
13 |
$16K |
| 90715 |
|
1,265 |
1,243 |
$15K |
| 75574 |
|
62 |
61 |
$14K |
| 74018 |
|
363 |
310 |
$14K |
| 72114 |
|
151 |
149 |
$14K |
| 76942 |
|
241 |
239 |
$14K |
| C1729 |
Catheter, drainage |
2,400 |
1,365 |
$14K |
| 80143 |
|
1,510 |
1,395 |
$13K |
| 80179 |
|
1,482 |
1,369 |
$13K |
| 12001 |
|
140 |
137 |
$13K |
| 80061 |
Lipid panel |
1,015 |
888 |
$13K |
| 84439 |
|
846 |
804 |
$12K |
| 10060 |
|
125 |
121 |
$12K |
| 64636 |
|
30 |
30 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,210 |
5,250 |
$11K |
| 85027 |
|
2,341 |
1,557 |
$10K |
| 76770 |
|
123 |
122 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
509 |
223 |
$10K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
144 |
136 |
$10K |
| 87070 |
|
991 |
837 |
$10K |
| 74183 |
|
25 |
25 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,235 |
6,413 |
$9K |
| 64447 |
|
12 |
12 |
$8K |
| 99406 |
|
516 |
505 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
466 |
457 |
$8K |
| 43235 |
|
26 |
24 |
$8K |
| 87075 |
|
684 |
569 |
$8K |
| 87650 |
|
291 |
286 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,604 |
4,079 |
$7K |
| 72040 |
|
87 |
87 |
$7K |
| 82150 |
|
540 |
528 |
$7K |
| 76937 |
|
125 |
121 |
$7K |
| 73700 |
|
41 |
40 |
$7K |
| 73560 |
|
129 |
126 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,231 |
734 |
$6K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
571 |
391 |
$6K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
48 |
24 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,149 |
3,038 |
$5K |
| 73080 |
|
104 |
102 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,660 |
3,412 |
$5K |
| 87632 |
|
37 |
35 |
$5K |
| 86140 |
|
787 |
686 |
$5K |
| 77334 |
|
19 |
15 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,587 |
2,699 |
$5K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
39 |
37 |
$5K |
| 93242 |
|
155 |
147 |
$5K |
| 93280 |
|
262 |
256 |
$5K |
| 94760 |
|
275 |
237 |
$5K |
| 87205 |
|
961 |
804 |
$5K |
| 99439 |
|
271 |
271 |
$4K |
| 82140 |
|
211 |
172 |
$4K |
| 97162 |
|
118 |
116 |
$4K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
12 |
12 |
$4K |
| 72141 |
|
13 |
13 |
$4K |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
533 |
512 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,473 |
1,970 |
$4K |
| 71101 |
|
53 |
52 |
$4K |
| 70496 |
|
12 |
12 |
$4K |
| 84481 |
|
198 |
191 |
$3K |
| 93297 |
|
474 |
465 |
$3K |
| 97116 |
|
206 |
133 |
$3K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
28 |
26 |
$3K |
| C1760 |
Closure device, vascular (implantable/insertable) |
49 |
45 |
$3K |
| 82330 |
|
270 |
162 |
$3K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,243 |
865 |
$3K |
| 85347 |
|
528 |
351 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
112 |
66 |
$3K |
| 85014 |
|
797 |
582 |
$3K |
| 82550 |
|
311 |
263 |
$3K |
| C1759 |
Catheter, intracardiac echocardiography |
25 |
25 |
$3K |
| 84132 |
|
534 |
357 |
$3K |
| A9270 |
Non-covered item or service |
5,916 |
1,866 |
$3K |
| 82553 |
|
201 |
169 |
$2K |
| 87634 |
|
69 |
67 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,678 |
1,501 |
$2K |
| 84100 |
|
490 |
203 |
$2K |
| 72110 |
|
25 |
24 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,359 |
1,236 |
$2K |
| 85652 |
|
374 |
357 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
47 |
36 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
886 |
719 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
31 |
31 |
$2K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
80 |
80 |
$1K |
| 73590 |
|
28 |
26 |
$1K |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
47 |
46 |
$1K |
| 72170 |
|
25 |
25 |
$1K |
| 85018 |
|
432 |
259 |
$1K |
| 86923 |
|
32 |
16 |
$1K |
| 72070 |
|
13 |
13 |
$1K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
421 |
373 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
877 |
768 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
282 |
255 |
$1K |
| 76870 |
|
13 |
12 |
$1K |
| 71271 |
|
13 |
13 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
906 |
375 |
$1K |
| 85007 |
|
292 |
269 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
438 |
429 |
$1K |
| 81025 |
|
146 |
143 |
$1K |
| 76801 |
|
13 |
13 |
$1K |
| 93284 |
|
65 |
63 |
$1K |
| 0296T |
|
13 |
13 |
$981.21 |
| 12002 |
|
12 |
12 |
$980.02 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
403 |
358 |
$953.83 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
88 |
83 |
$910.84 |
| 93298 |
|
176 |
170 |
$898.78 |
| 72050 |
|
13 |
12 |
$891.73 |
| 84295 |
|
121 |
97 |
$888.52 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
153 |
141 |
$790.93 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
726 |
711 |
$778.51 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
122 |
110 |
$748.10 |
| 80050 |
General health panel |
24 |
23 |
$683.03 |
| 93978 |
|
12 |
12 |
$670.11 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
480 |
444 |
$669.69 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
383 |
316 |
$654.99 |
| C1766 |
Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
12 |
12 |
$484.98 |
| 97802 |
|
28 |
28 |
$467.83 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
186 |
176 |
$466.31 |
| A4615 |
Cannula, nasal |
1,917 |
1,849 |
$464.96 |
| 80076 |
|
31 |
29 |
$459.89 |
| J3480 |
Injection, potassium chloride, per 2 meq |
70 |
52 |
$424.00 |
| 82565 |
|
99 |
95 |
$412.37 |
| J2305 |
Injection, nitroglycerin, 5 mg |
165 |
161 |
$361.37 |
| 84134 |
|
27 |
26 |
$352.80 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
236 |
174 |
$343.41 |
| J1790 |
Injection, droperidol, up to 5 mg |
281 |
266 |
$343.07 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
124 |
120 |
$321.05 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
572 |
463 |
$313.25 |
| 87641 |
|
17 |
12 |
$312.73 |
| J1940 |
Injection, furosemide, up to 20 mg |
312 |
245 |
$311.04 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
233 |
115 |
$299.95 |
| J3490 |
Unclassified drugs |
13 |
13 |
$229.23 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
132 |
130 |
$177.18 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
55 |
53 |
$146.11 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
29 |
27 |
$134.05 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
230 |
223 |
$131.52 |
| 99487 |
Ccm add 20min |
15 |
15 |
$114.76 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
29 |
25 |
$113.76 |
| 89051 |
|
20 |
13 |
$94.49 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
150 |
138 |
$93.80 |
| 84145 |
|
15 |
12 |
$90.11 |
| J3360 |
Injection, diazepam, up to 5 mg |
36 |
35 |
$87.21 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
114 |
99 |
$86.46 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
30 |
25 |
$68.16 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
12 |
12 |
$64.48 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
26 |
26 |
$60.82 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
80 |
80 |
$49.70 |
| J1630 |
Injection, haloperidol, up to 5 mg |
27 |
26 |
$30.69 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
14 |
13 |
$20.53 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
25 |
25 |
$20.31 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$19.64 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
13 |
12 |
$17.44 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,067 |
847 |
$0.01 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
204 |
199 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
203 |
198 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
84 |
82 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
137 |
132 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
203 |
198 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
136 |
131 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
15 |
15 |
$0.00 |
| 77001 |
|
13 |
12 |
$0.00 |
| 99489 |
Ccm add 20min |
15 |
15 |
$0.00 |